{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:40:09Z","timestamp":1751298009958,"version":"3.41.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Gastroesophageal reflux disease (GERD) is very common in high-income countries. Nonerosive GERD is increasingly being considered a different entity from erosive GERD, with a more benign disease course but less responsiveness to antireflux medication. Whether nonerosive GERD responds less well than erosive GERD to antireflux surgery is unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess whether patients with nonerosive GERD retain more reflux symptoms after antireflux surgery than patients with erosive GERD.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This population-based cohort study included all patients in Finland and Sweden who underwent primary laparoscopic fundoplication for GERD between January 1, 1996, and December 31, 2019. Statistical analysis was conducted from March to April 2024.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Patients with nonerosive GERD (ie, no erosive esophagitis or Barrett esophagus detected during preoperative endoscopy) were compared with patients with erosive GERD (ie, erosive esophagitis detected during preoperative endoscopy).<\/jats:p><\/jats:sec>Main Outcome and Measures<\/jats:title>The main outcome was reflux recurrence, defined as 6 months or more of postoperative antireflux medication or secondary antireflux surgery. Poisson regression provided hazard ratios (HRs) with 95% CIs, adjusted for sex, age, comorbidity, hospital volume of antireflux surgery, calendar year, and country.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 6194 patients (median age, 53 years [IQR, 42-62 years]; 3310 women [53.4%]) who underwent primary fundoplication, 2700 (43.6%) received a diagnosis of nonerosive GERD, and 3494 (56.4%) received a diagnosis of erosive GERD. During up to 23 years of follow-up (range, 0-23 years; median, 8.8 person-years [IQR, 4.3-13.5 person-years]), the frequency of reflux recurrence was similar among patients with nonerosive GERD (17.1% [461 of 2700]) and those with erosive GERD (17.1% [596 of 3494]). Patients with nonerosive GERD had a similar overall risk of reflux recurrence as patients with erosive GERD (adjusted HR, 0.98; 95% CI, 0.87-1.11) and a similar risk of reflux recurrence when studying recurrence by antireflux medication (HR, 1.04; 95% CI, 0.90-1.21) and secondary antireflux surgery (HR, 0.91; 95% CI, 0.75-1.10) separately. There were no differences in HRs between various follow-up categories after fundoplication or in analyses stratified by the 6 variables included in the multivariable model.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cohort study of patients who underwent primary laparoscopic fundoplication suggests that the risk of reflux recurrence was similar among patients with nonerosive GERD and those with erosive GERD. This finding is in contrast with evidence showing that nonerosive GERD responds less well to antireflux medication. Thus, the absence of erosive GERD detected by an upper endoscopy may not be used as an argument for abstaining from antireflux surgery.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.17754","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:00:17Z","timestamp":1751295617000},"page":"e2517754","source":"Crossref","is-referenced-by-count":0,"title":["Reflux Recurrence After Laparoscopic Fundoplication for Nonerosive Gastroesophageal Reflux Disease"],"prefix":"10.1001","volume":"8","author":[{"given":"Dag","family":"Holmberg","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Bielik","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giola","family":"Santoni","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eivind","family":"Ness-Jensen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Medical Department, Levanger Hospital, Nord-Tr\u00f8ndelag Hospital Trust, Levanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"My","family":"von Euler-Chelpin","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonas H.","family":"Kauppila","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden"},{"name":"School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"zoi250561r1","doi-asserted-by":"publisher","first-page":"m3786","DOI":"10.1136\/bmj.m3786","article-title":"Advances in the diagnosis and management of gastroesophageal reflux disease.","volume":"371","author":"Katzka","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"zoi250561r2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.","volume":"67","author":"Eusebi","year":"2018","journal-title":"Gut"},{"issue":"24","key":"zoi250561r3","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1001\/jama.2020.21360","article-title":"Gastroesophageal reflux disease: a review.","volume":"324","author":"Maret-Ouda","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"zoi250561r4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus.","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut"},{"key":"zoi250561r5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076017","article-title":"Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study.","volume":"382","author":"Holmberg","year":"2023","journal-title":"BMJ"},{"issue":"8","key":"zoi250561r6","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/j.1572-0241.2008.01892.x","article-title":"Barrett\u2019s esophagus on repeat endoscopy: should we look more than once?","volume":"103","author":"Rodriguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"16","key":"zoi250561r7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","article-title":"Randomized trial of medical versus surgical treatment for refractory heartburn.","volume":"381","author":"Spechler","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi250561r8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrgastro.2016.50","article-title":"Management of refractory typical GERD symptoms.","volume":"13","author":"Scarpellini","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"zoi250561r9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01888.x","author":"Weijenborg","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"zoi250561r10","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1053\/j.gastro.2019.12.014","article-title":"Prevalence of gastroesophageal reflux disease and proton pump inhibitor\u2013refractory symptoms.","volume":"158","author":"Delshad","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"zoi250561r11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in nonerosive reflux disease.","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"zoi250561r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016505","article-title":"Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo).","volume":"7","author":"Maret-Ouda","year":"2017","journal-title":"BMJ Open"},{"key":"zoi250561r13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"6","key":"zoi250561r14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish Hospital Discharge Register: a systematic review.","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"issue":"10","key":"zoi250561r15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jama.2017.10981","article-title":"Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux.","volume":"318","author":"Maret-Ouda","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"zoi250561r16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/SLA.0000000000003131","article-title":"Reintervention after antireflux surgery for gastroesophageal reflux disease in England.","volume":"271","author":"Markar","year":"2020","journal-title":"Ann Surg"},{"issue":"7","key":"zoi250561r17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months.","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"zoi250561r18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3414\/ME17-01-0051","article-title":"The Charlson Comorbidity Index in registry-based research.","volume":"56","author":"Brusselaers","year":"2017","journal-title":"Methods Inf Med"},{"issue":"6","key":"zoi250561r19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/bjs.7023","article-title":"Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease.","volume":"97","author":"Broeders","year":"2010","journal-title":"Br J Surg"},{"issue":"4","key":"zoi250561r20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1365-2036.2006.03024.x","article-title":"Antireflux surgery for non-erosive and erosive reflux disease in community practice.","volume":"24","author":"Thibault","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"zoi250561r21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S1091-255X(02)00042-2","article-title":"Outcome of laparoscopic antireflux surgery in patients with nonerosive reflux disease.","volume":"6","author":"Bammer","year":"2002","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"zoi250561r22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1091-255X(02)00135-X","article-title":"Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis.","volume":"7","author":"Desai","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"zoi250561r23","doi-asserted-by":"publisher","DOI":"10.1007\/s00104-006-1246-8","author":"Gockel","year":"2007","journal-title":"Chirurg"},{"issue":"2","key":"zoi250561r24","first-page":"222","article-title":"Preoperative endoscopic grading of esophagitis versus outcome after laparoscopic Nissen fundoplication.","volume":"92","author":"Watson","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"zoi250561r25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00464-003-9267-6","article-title":"Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease: long-term quality-of-life assessment and surgical outcome.","volume":"19","author":"Kamolz","year":"2005","journal-title":"Surg Endosc"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2835800\/holmberg_2025_oi_250561_1750697078.80721.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:00:18Z","timestamp":1751295618000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2835800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.17754","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}